Brian L. Egleston, Ph.D.
Affiliations: | 2006 | Johns Hopkins University, Baltimore, MD |
Area:
Statistics, Ophthalmology, Public Health, Biostatistics BiologyGoogle:
"Brian Egleston"Cross-listing: PHTree
Parents
Sign in to add mentorDaniel O. Scharfstein | grad student | 2006 | Johns Hopkins | |
(Causal inference with sensitivity analysis: Methods for investigating mediation and accounting for death in observational studies.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Bradbury AR, Egleston BL, Patrick-Miller LJ, et al. (2020) Longitudinal outcomes with cancer multigene panel testing in previously tested BRCA1/2 negative patients. Clinical Genetics |
Liu JC, Egleston B, Blackman E, et al. (2020) Abstract 1175: Race informs survival disparities in head and neck cancer clinical trials Epidemiology. 80: 1175-1175 |
Bauman J, Panick J, Galloway T, et al. (2020) A Pilot Study of a Comprehensive Palliative Care Intervention to Improve Symptoms and Coping During Curative-Intent Chemoradiation in Patients with Head and Neck Cancer International Journal of Radiation Oncology*Biology*Physics. 106: 1208 |
Jones EA, Shuman AG, Egleston BL, et al. (2019) Common Pitfalls of Head and Neck Research Using Cancer Registries. Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery. 194599819838823 |
Bauman JR, Panick J, Galloway TJ, et al. (2019) Feasibility of a collaborative palliative and oncology care intervention to improve symptoms and coping during head and neck chemoradiation. Journal of Clinical Oncology. 37: 73-73 |
Zhang E, Deng M, Egleston B, et al. (2019) Dose to Heart, Spine, Aorta, and Body Predict for Severe Lymphopenia and Poor Survival in Patients Undergoing Chemoradiation for Esophageal Cancer International Journal of Radiation Oncology*Biology*Physics. 105: E206-E207 |
Burbure N, Egleston B, Paly J, et al. (2019) Long-Term Quality of Life Outcomes for High Risk Prostate Cancer Patients after Primary Treatment with Surgery Vs Radiation + ADT International Journal of Radiation Oncology*Biology*Physics. 105: E267 |
Beri N, Patrick-Miller LJ, Egleston BL, et al. (2018) Preferences for in-person disclosure: Patients declining telephone disclosure characteristics and outcomes in the multi-center COGENT Study. Clinical Genetics |
Frost CJ, Andrulis IL, Buys SS, et al. (2018) Assessing patient readiness for personalized genomic medicine. Journal of Community Genetics |
Bradbury AR, Patrick-Miller LJ, Egleston BL, et al. (2018) Randomized Noninferiority Trial of Telephone vs In-Person Disclosure of Germline Cancer Genetic Test Results. Journal of the National Cancer Institute |